196 related articles for article (PubMed ID: 34497765)
1. Second Primary Malignancies in Patients With Hepatocellular Carcinoma: A Population-Based Analysis.
Kong J; Yu G; Si W; Li G; Chai J; Liu Y; Liu J
Front Oncol; 2021; 11():713637. PubMed ID: 34497765
[TBL] [Abstract][Full Text] [Related]
2. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
Jia H; Li Q; Yuan J; Sun X; Wu Z
Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
[TBL] [Abstract][Full Text] [Related]
3. Risk Prediction of Second Primary Malignancies in Primary Early-Stage Ovarian Cancer Survivors: A SEER-Based National Population-Based Cohort Study.
Xu J; Huang C; Wu Z; Xu H; Li J; Chen Y; Wang C; Zhu J; Qin G; Zheng X; Yu Y
Front Oncol; 2022; 12():875489. PubMed ID: 35664751
[TBL] [Abstract][Full Text] [Related]
4. Survival analysis of second primary malignancies after cervical cancer using a competing risk model: implications for prevention and surveillance.
Li R; Zhang Y; Ma B; Tan K; Lynn HS; Wu Z
Ann Transl Med; 2021 Feb; 9(3):239. PubMed ID: 33708866
[TBL] [Abstract][Full Text] [Related]
5. Risk prediction of second primary malignancies in primary colorectal neuroendocrine neoplasms patients: a population-based study.
Ding X; Yang X; Hao Q; Xu F; Yu X; Rao L; Yuan C; Tian S
J Endocrinol Invest; 2023 Sep; 46(9):1881-1889. PubMed ID: 36870016
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation: A SEER-based Analysis.
Ding Q; Wang K; Li Y; Peng P; Zhang D; Chang D; Wang W; Ren L; Tang F; Li Z
Am J Clin Oncol; 2023 Jul; 46(7):284-292. PubMed ID: 37145881
[TBL] [Abstract][Full Text] [Related]
7. Risk prediction of second primary malignancies after gynecological malignant neoplasms resection with and without radiation therapy: a population-based surveillance, epidemiology, and end results (SEER) analysis.
Wang J; Zhang C; Xiang Y; Han B; Cheng Y; Tong Y; Yan D
J Cancer Res Clin Oncol; 2023 Nov; 149(14):12703-12711. PubMed ID: 37452852
[TBL] [Abstract][Full Text] [Related]
8. Risk of Second Primary Malignancies in Colon Cancer Patients Treated With Colectomy.
Zhang B; Guo K; Zheng X; Sun L; Shen M; Ruan S
Front Oncol; 2020; 10():1154. PubMed ID: 32766153
[No Abstract] [Full Text] [Related]
9. Mortality patterns of patients with tonsillar squamous cell carcinoma: a population-based study.
Wang J; Li X; Niu D; Huang J; Ye E; Zhao Y; Yue S; Hou X; Wu J
Front Endocrinol (Lausanne); 2023; 14():1158593. PubMed ID: 38130394
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of nomograms to predict the survival probability and occurrence of a second primary malignancy of male breast cancer patients: a population-based analysis.
Huang H; Li Z; Huang Z; Huang L; Liu W; Liu G; Mo Y
Front Oncol; 2023; 13():1076997. PubMed ID: 37152061
[TBL] [Abstract][Full Text] [Related]
11. Analysis of chemotherapy effect on the second primary malignancy for head and neck cancer patients by a nomogram based on SEER database.
Li X; Guo K; Feng Y; Guo Y
Cancer Med; 2020 Nov; 9(21):8029-8042. PubMed ID: 32931661
[TBL] [Abstract][Full Text] [Related]
12. A nomogram predicting the prognosis of young adult patients diagnosed with hepatocellular carcinoma: A population-based analysis.
Kong J; Wang T; Shen S; Zhang Z; Wang W
PLoS One; 2019; 14(7):e0219654. PubMed ID: 31295310
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
Yang J; Wu F; An H; Gan H
Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483
[TBL] [Abstract][Full Text] [Related]
14. A Novel Overall Survival Nomogram Prediction of Secondary Primary Malignancies after Hypopharyngeal Cancer: A Population-Based Study.
Wan M; Zhao D; Sun Y; Wang W
J Oncol; 2022; 2022():4681794. PubMed ID: 35528241
[TBL] [Abstract][Full Text] [Related]
15. A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma.
Yan B; Su BB; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
Cancer Med; 2021 Jan; 10(2):496-506. PubMed ID: 33280269
[TBL] [Abstract][Full Text] [Related]
16. A competing-risks nomogram and recursive partitioning analysis for cause-specific mortality in patients with esophageal neuroendocrine carcinoma.
Zhang G; Wu B; Wang X; Li J
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30715226
[TBL] [Abstract][Full Text] [Related]
17. Nomogram for Predicting the Prognosis of Patients with Hepatocellular Carcinoma Presenting with Pulmonary Metastasis.
Zhou Y; Zhou X; Ma J; Zhang W; Yan Z; Luo J
Cancer Manag Res; 2021; 13():2083-2094. PubMed ID: 33688251
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Outcomes in the Patients With Colorectal Cancer: A Multi-Registry-Based Cohort Study of 197,699 Cases in the Real World.
Zhang S; Wang Y; Zhang P; Ai L; Liu T
Front Cardiovasc Med; 2022; 9():851833. PubMed ID: 35783821
[TBL] [Abstract][Full Text] [Related]
19. Risk of second primary malignancy after non-small cell lung cancer: a competing risk nomogram based on the SEER database.
Zhou H; Shen J; Zhang Y; Huang Y; Fang W; Yang Y; Hong S; Liu J; Xian W; Zhang Z; Ma Y; Zhou T; Zhao H; Zhang L
Ann Transl Med; 2019 Sep; 7(18):439. PubMed ID: 31700875
[TBL] [Abstract][Full Text] [Related]
20. Developing a competing risk nomogram that predicts the survival of patients with a primary hepatic neuroendocrine tumor.
Lin J; Li X; Ding X; Chen Z; Wu Y; Zhao K
Front Med (Lausanne); 2022; 9():960235. PubMed ID: 36425110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
